Viatris Inc. announces divestitures in key business sectors: Comprehensive breakdown
Viatris Inc. (NASDAQ: VTRS), a frontrunner in global healthcare, has unveiled a series of divestitures in its business framework. Leading the announcements, Viatris is set ... Read More
Granules India gets Venlafaxine ER Capsules FDA approval
Granules India has secured approval for its abbreviated new drug application (ANDA) for Venlafaxine Hydrochloride Extended-Release (ER) Capsules USP, 37.5 mg, 75 mg, and 150 ... Read More
Marksans Pharma gets FDA approval for Pregabalin Capsules
Marksans Pharma has secured final approval for its abbreviated new drug application (ANDA) for Pregabalin Capsules from the US Food & Drugs Administration (FDA). The approval ... Read More
FTC gives conditional approval to Mylan’s acquisition of Upjohn from Pfizer
The US Federal Trade Commission (FTC) has granted conditional approval for Dutch pharma company Mylan’s acquisition of Upjohn, the off-patent branded and generic established medicines ... Read More